Express News | Avantor® Strengthens Partnership With National Institute for Bioprocessing Research and Training (Nibrt) to Address Critical Biopharma Industry Challenges
Avantor Strengthens Partnership With National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
Morgan Stanley Maintains Avantor(AVTR.US) With Buy Rating, Cuts Target Price to $28
Morgan Stanley Sticks to Their Buy Rating for Avantor (AVTR)
Earnings Preview: Avantor to Report Financial Results Pre-market on October 25
$Avantor(AVTR.US)$ is scheduled to release its financial results pre-market on October 25 ET. Earnings PreviewAnalysts estimate $Avantor(AVTR.US)$ to post revenue of USD1.73B for 2024Q3, up 0.28% YOY;
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions
Avantor Sees About $500 Million After-Tax Cash Proceeds, Reduction of About $50 Million in Capitalized Leases >AVTR
Express News | Avantor® Closes Previously Announced Divestiture of Its Clinical Services Business
Avantor Closes Previously Announced Divestiture of Its Clinical Services Business
P/E Ratio Insights for Avantor
Unusual Options Activity: APO, AKAM and Others Attract Market Bets, APO V/OI Ratio Reaches 106.4
EST Oct 17th Afternoon Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Express News | Thermo Fisher up 2.3%, Danaher up 2.6%, Waters up 2.5%, Avantor up 4.5%
Express News | Shares of US Life Sciences Companies Rise After Peer Sartorius Posts Better-Than-Expected Nine-Month Results
Barclays Maintains Avantor(AVTR.US) With Buy Rating, Maintains Target Price $28
Avantor (AVTR) Gets a Buy From Barclays
Morgan Stanley Screens for Quality Cyclicals as Economic Surprises, Yields Back Upgrade
Solid Execution Lifted Avantor (AVTR) in Q3
UBS Maintains Avantor(AVTR.US) With Buy Rating, Raises Target Price to $29
Avantor Is Maintained at Buy by UBS